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Historical background
Since its beginnings (first decade of the 20th
century), chemical engineering has undergone sev-
eral and fundamental transformations. Indeed, the
affirmation of the concept of “unit operation” (dis-
tillation, extraction, filtration, crystallization, and so
on) marked the definitive detachment of chemical
engineering from the original chemistry frame1.
The idea that each “unit operation” was governed
by its own distinct principles was definitively over-
come in 1960 when some valuable researchers (in
particular Neal R. Amundson, Rutherford Aris, R.
Byron Bird, Edwin N. Lightfoot and Warren E.
Stewart) affirmed that all the “unit operations” are
connected by a unique leading concept represented
by the mass, energy and momentum balance. This
situation represented the ideal background for an-
other important transformation of Chemical Engi-
neering, i.e the development of the so called Bio-
medical Engineering1. Although a clear evidence of
the extension of the cultural horizons of Chemical
Engineering was felt only in the mid 1970s, the
seed of Biochemical Engineering must be searched
in the early 1960s when valuable researchers (such
as, for example, Elmer L. Gaden, Arthur B.
Metzner, R. Byron Bird, Edward W. Merrill) under-
stood that the concept of balance (mass, energy and
momentum) could be profitably applied also to
knowledge fields, such as medicine, biology, phar-
macy and psychology, that were, traditionally, far
from Chemical Engineering. In so doing, these re-
searchers introduced the concept of interdisciplin-
ary that is so important in the modern research and
that represents, according to me, the winning strat-
egy also for the future.
State of the art
Undoubtedly, the attitude of chemical engi-
neers to transfer laboratory findings to the practical
level and the rapid improvement of personal com-
puters favoured the development of Biomedical En-
gineering. Indeed, Chemical Engineering could
contribute to the above mentioned not traditional
knowledge fields in different ways among which, in
my opinion, one of the most important was repre-
sented by mathematical modelling2. As a mathemat-
ical model can be defined as a mathematical meta-
phor of some aspects of reality (objects and devices
behaviour)3, mathematical modelling is a cognitive
activity of human mind that requires a deep knowl-
edge of the phenomena under study and good math-
ematical skills. Accordingly, mathematical model-
ling implied the merging of typical (chemical) engi-
neers skills with those of pharmacists, biologists,
medical doctors, psychologists and so on, to get
common and higher results. In so doing, mathemat-
ical modelling has become a common tool over-
coming the cultural barrier existing among the dif-
ferent knowledge fields and it has given a funda-
mental improvement to the interdisciplinary ap-
proach. In other words, both chemical engineers
and biomedical researchers recognised the cultur-
ally transversal role of mathematical modelling.
The scientific literature is full of examples about
this interdisciplinary approach1,2,4,5 and it is not pos-
sible mentioning all of them in this preface. How-
ever, it is sure that, following the path underwent
by very important researchers such as, for example,
Higuchi and Peppas, a great part of the mathemati-
cal modelling activity was devoted to the study of
drug release from the many kinds of release sys-
tems available. This aspect is also witnessed by the
topics matched in this special issue on drug deliv-
ery. Indeed, 53% of the papers deal with the prob-
lem of release kinetics, 20% are about the charac-
terisation of the polymeric matrix devoted to the
drug release, 13% match the problem of the
bioavailability enhancement of poorly soluble
drugs, 7% are devoted to the in silico designing of
nano-vectors and 7% are about the modelling of
stem cells differentiation. Interestingly, the interdis-
ciplinary character of these papers is underlined by
the cultural provenience of their authors that are
chemical engineers, material engineers, pharma-
cists, biologists and medical doctors.
Future developments
As recently pointed out by Siepmann6, I agree7
with the convincement that one of the new chal-
lenge for Biomedical Engineering is the combina-
tion of mechanistic theories able to realistically de-
scribe the simultaneous processes of drug release
and the subsequent ADME processes (drug Adsorp-
tion, Distribution, Metabolisation and Elimination)
within the human body. A further, subsequent, chal-
lenge relies on pharmacodynamics, i.e the predic-
tion of the effect of a drug released from a specific
delivery system8. This aspect is not only important
per se, but it acquires considerable relevance in the
light of the emerging concept of “personalised med-
icine”9 whose target is to optimize the dose regimen
for each patient. Accordingly, we are proceeding
towards the Leonardo da Vinci concept of true
science: “niuna umana investigazione si può
dimandare vera scienzia, s’essa non passa per le
matematiche dimostrazioni” (no human investiga-
tion can be defined true science if it cannot be
mathematically demonstrated)10. Thus, the mathe-
matical model becomes the theoretical legitimacy
of the experimental findings.
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